Company News: Curetis Appoints Dr. Klaus Brinkmann as Director of Sales

– Preparation of CE-marking and product launch in Europe in 2012 –

Curetis AG, an innovative molecular diagnostics company focusing on the development and commercialization of in-vitro diagnostic products for infectious diseases, today announced that Dr. Klaus Brinkmann has joined its management team as Director of Sales.

Dr. Klaus Brinkmann is a seasoned executive with extensive commercial expertise in setting-up sales organizations and infrastructures and leading sales teams in very competitive markets. He has an outstanding track record in the commercialization of complex in vitro diagnostics (IVD). His experience covers instrument platforms as well as test kits in the areas of immunology, traditional microbiology and molecular-based infectious disease testing. He joins Curetis from BioRad Laboratories GmbH, where he has been Account Manager Lab Automation. Previously, he held various sales management positions with Becton Dickinson GmbH and Beckman Coulter GmbH. Klaus Brinkmann studied chemistry and holds a doctorate from Justus Liebig University Giessen, Germany.